Federated Hermes’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $246K | Sell |
71,217
-25,096
| -26% | -$86.8K | ﹤0.01% | 1462 |
|
|
2025
Q1 | $252K | Buy |
96,313
+46,213
| +92% | +$121K | ﹤0.01% | 1460 |
|
|
2024
Q4 | $206K | Buy |
50,100
+42,231
| +537% | +$174K | ﹤0.01% | 1480 |
|
|
2024
Q3 | $55.7K | Sell |
7,869
-304,575
| -97% | -$2.16M | ﹤0.01% | 1637 |
|
|
2024
Q2 | $2.04M | Sell |
312,444
-24,046
| -7% | -$157K | ﹤0.01% | 919 |
|
|
2024
Q1 | $2.79M | Buy |
+336,490
| New | +$2.79M | 0.01% | 850 |
|
|
2022
Q1 | – | Sell |
-600,000
| Closed | -$18.4M | – | 2289 |
|
|
2021
Q4 | $18.4M | Hold |
600,000
| – | – | 0.03% | 509 |
|
|
2021
Q3 | $18.9M | Hold |
600,000
| – | – | 0.04% | 480 |
|
|
2021
Q2 | $22M | Sell |
600,000
-218,309
| -27% | -$7.99M | 0.04% | 454 |
|
|
2021
Q1 | $28.3M | Buy |
818,309
+250,000
| +44% | +$8.64M | 0.05% | 407 |
|
|
2020
Q4 | $23.6M | Buy |
568,309
+68,309
| +14% | +$2.84M | 0.05% | 427 |
|
|
2020
Q3 | $21.3M | Buy |
+500,000
| New | +$21.3M | 0.05% | 395 |
|